Cargando…

The Role of Cytotoxic T-Lymphocyte Antigen 4 in the Pathogenesis of Multiple Sclerosis

Multiple sclerosis (MS) is an autoimmune neurodegenerative disorder of the central nervous system that presents heterogeneous clinical manifestations and course. It has been shown that different immune checkpoints, including Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4), can be involved in the pathogene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Basile, Maria Sofia, Bramanti, Placido, Mazzon, Emanuela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394409/ https://www.ncbi.nlm.nih.gov/pubmed/35893056 http://dx.doi.org/10.3390/genes13081319

Ejemplares similares

The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets
por: Mammana, Santa, et al.
Publicado: (2018)

Comparison of efficacy and safety of oral agents for the treatment of relapsing–remitting multiple sclerosis
por: Guarnera, Cristina, et al.
Publicado: (2017)

Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis
por: Guarnera, Cristina, et al.
Publicado: (2017)

The Gut Microbiota in Multiple Sclerosis: An Overview of Clinical Trials
por: Schepici, Giovanni, et al.
Publicado: (2019)

Mesenchymal Stem Cells in Multiple Sclerosis: Recent Evidence from Pre-Clinical to Clinical Studies
por: Gugliandolo, Agnese, et al.
Publicado: (2020)

Inosine in Neurodegenerative Diseases: From the Bench to the Bedside
por: Basile, Maria Sofia, et al.
Publicado: (2022)

Mesenchymal Stem Cells: A Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis?
por: Gugliandolo, Agnese, et al.
Publicado: (2019)

Identification of CD4(+) T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment
por: Fagone, Paolo, et al.
Publicado: (2019)

The Italian Pharmacovigilance Program: An Observational Study of Adverse Effects of Natalizumab in Multiple Sclerosis Therapy
por: Giacoppo, Sabrina, et al.
Publicado: (2017)

Could the Heat Shock Proteins 70 Family Members Exacerbate the Immune Response in Multiple Sclerosis? An in Silico Study
por: Chiricosta, Luigi, et al.
Publicado: (2020)

Role of miRNAs in Alzheimer’s Disease and Possible Fields of Application
por: Silvestro, Serena, et al.
Publicado: (2019)

Topical moringin cream relieves neuropathic pain by suppression of inflammatory pathway and voltage-gated ion channels in murine model of multiple sclerosis
por: Giacoppo, Sabrina, et al.
Publicado: (2017)

Role of Vitamin E in the Treatment of Alzheimer’s Disease: Evidence from Animal Models
por: Gugliandolo, Agnese, et al.
Publicado: (2017)

Upregulated Expression of Macrophage Migration Inhibitory Factor, Its Analogue D-Dopachrome Tautomerase, and the CD44 Receptor in Peripheral CD4 T Cells from Clinically Isolated Syndrome Patients with Rapid Conversion to Clinical Defined Multiple Sclerosis
por: Cavalli, Eugenio, et al.
Publicado: (2019)

Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis
por: Mammana, Santa, et al.
Publicado: (2018)

Modulation of Tetraspanin 32 (TSPAN32) Expression in T Cell-Mediated Immune Responses and in Multiple Sclerosis
por: Lombardo, Salvo Danilo, et al.
Publicado: (2019)

In Vitro-Transcribed mRNA Chimeric Antigen Receptor T Cell (IVT mRNA CAR T) Therapy in Hematologic and Solid Tumor Management: A Preclinical Update
por: Soundara Rajan, Thangavelu, et al.
Publicado: (2020)

Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach
por: Mangano, Katia, et al.
Publicado: (2018)

Anti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL-37
por: Giacoppo, Sabrina, et al.
Publicado: (2017)

The combined strategy of mesenchymal stem cells and tissue-engineered scaffolds for spinal cord injury regeneration
por: Libro, Rosaliana, et al.
Publicado: (2017)

Overview on the Effects of N-Acetylcysteine in Neurodegenerative Diseases
por: Tardiolo, Giuseppe, et al.
Publicado: (2018)

Migraine: Experimental Models and Novel Therapeutic Approaches
por: Tardiolo, Giuseppe, et al.
Publicado: (2019)

Activation of Nrf2 by Natural Bioactive Compounds: A Promising Approach for Stroke?
por: Gugliandolo, Agnese, et al.
Publicado: (2020)

Efficacy of Sulforaphane in Neurodegenerative Diseases
por: Schepici, Giovanni, et al.
Publicado: (2020)

Overexpression of macrophage migration inhibitory factor and functionally-related genes, D-DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma
por: Presti, Mario, et al.
Publicado: (2018)

Use of Natural Compounds in the Management of Diabetic Peripheral Neuropathy
por: Maria, Galuppo, et al.
Publicado: (2014)

Human periodontal ligament stem cells secretome from multiple sclerosis patients suppresses NALP3 inflammasome activation in experimental autoimmune encephalomyelitis
por: Soundara Rajan, Thangavelu, et al.
Publicado: (2017)

MicroRNAs Modulate the Pathogenesis of Alzheimer’s Disease: An In Silico Analysis in the Human Brain
por: Gugliandolo, Agnese, et al.
Publicado: (2020)

The Role of Cannabinoid Type 2 Receptors in Parkinson’s Disease
por: Basile, Maria Sofia, et al.
Publicado: (2022)

Caffeine: An Overview of Its Beneficial Effects in Experimental Models and Clinical Trials of Parkinson’s Disease
por: Schepici, Giovanni, et al.
Publicado: (2020)

Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease
por: Silvestro, Serena, et al.
Publicado: (2020)

Stem Cells Therapy for Spinal Cord Injury: An Overview of Clinical Trials
por: Silvestro, Serena, et al.
Publicado: (2020)

Autism Spectrum Disorder and miRNA: An Overview of Experimental Models
por: Schepici, Giovanni, et al.
Publicado: (2019)

Traumatic Brain Injury and Stem Cells: An Overview of Clinical Trials, the Current Treatments and Future Therapeutic Approaches
por: Schepici, Giovanni, et al.
Publicado: (2020)

A State of the Art of Antioxidant Properties of Curcuminoids in Neurodegenerative Diseases
por: Silvestro, Serena, et al.
Publicado: (2021)

Administration of 4-(α-L-Rhamnosyloxy)-benzyl Isothiocyanate Delays Disease Phenotype in SOD1(G93A) Rats: A Transgenic Model of Amyotrophic Lateral Sclerosis
por: Galuppo, Maria, et al.
Publicado: (2015)

Retrospective follow-up analysis of the transcriptomic patterns of cytokines, cytokine receptors and chemokines at preconception and during pregnancy, in women with post-partum depression
por: Petralia, Maria Cristina, et al.
Publicado: (2019)

Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases
por: Giacoppo, Sabrina, et al.
Publicado: (2014)

Tunneling Nanotubes-Mediated Protection of Mesenchymal Stem Cells: An Update from Preclinical Studies
por: Soundara Rajan, Thangavelu, et al.
Publicado: (2020)

A multicentric pharmacovigilance study: collection and analysis of adverse drug reactions in relapsing-remitting multiple sclerosis patients
por: Gugliandolo, Agnese, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0k69chnjhb4ncpor7qo1heejss